The Mitochondrial Information Processing System (MIPS) model, proposed by Picard & Shirihai (2022), redefines mitochondria as central integrators that convert psychological, social, and environmental signals into biological responses through three sequential steps: sensing, integration, and transduction. This framework mechanistically explains how non-physical stressors become somatic disease by physically altering mitochondrial function, energy allocation, and intercellular communication.
Think of mitochondria as the building's smart thermostat system — not just a heater that produces warmth (ATP), but an intelligent hub that monitors the outside temperature (social stress), indoor activity (metabolic demand), humidity (inflammation), and the building's schedule (circadian rhythm). When the system detects a cold snap (psychological stress), it doesn't just crank up the heat blindly. Instead, it integrates multiple sensors: Are the windows open? (Autonomic nervous system signals). Is anyone home? (Insulin signaling). Is there a fire alarm going off elsewhere? (inflammatory cytokines). Based on this integrated data, the thermostat doesn't just adjust temperature — it sends alerts to other building systems (mitokines to distant organs), changes the humidity settings (ROS production), records the event in the building's logbook (Epigenetic Modifications), and even releases maintenance reports (cell-free mtDNA) that other buildings can read. A broken thermostat doesn't just make one room cold — it dysregulates the entire building's homeostasis, explains why "feeling cold" (psychological distress) can literally damage pipes (cellular function).
The MIPS model operates through three mechanistically distinct phases:
Mitochondria detect extracellular and intracellular signals via multiple receptor pathways:
- Autonomic signals: Catecholamines (epinephrine, norepinephrine) bind β-adrenergic receptors → activate PKA → phosphorylate mitochondrial fission/fusion proteins (Drp1, OPA1)
- Metabolic signals: Insulin/IGF-1 → activate AKT pathway → phosphorylate FOXO1 (nuclear exclusion) + mTORC1 (anabolic signaling)
- Inflammatory signals: IL-6, TNF-α → JAK-STAT pathway + NF-κB activation → alter mitochondrial biogenesis via PGC-1α suppression
- Nutrient status: AMP:ATP ratio → AMPK activation → PGC-1α phosphorylation
- Oxidative signals: ROS levels detected by mitochondrial peroxiredoxins and thioredoxins
Signals converge at mitochondria-associated membranes (MAMs) — physical contact sites between mitochondria and ER (20-30 nm gap, 5-20% of mitochondrial surface):
MAM resident proteins:
- MFN2 (mitofusin-2): tethers mitochondria to ER
- PACS2: regulates MAM formation
- IP3R-VDAC-GRP75: Ca²⁺ transfer channel complex
- PERK: ER stress sensor
- AMPK, mTORC2: metabolic integrators
MAMs enable:
- Ca²⁺ microdomain signaling (mitochondria ↔ ER communication)
- Lipid biosynthesis (phosphatidylserine synthesis site)
- Autophagy initiation (BNIP3, BNIP3L recruitment)
- Inflammasome assembly (NLRP3 activation)
- Nuclear signaling via physical proximity to nuclear envelope
Integrated signals produce multiple outputs:
Metabolic outputs:
- ATP/ROS ratio adjustment (oxidative phosphorylation vs glycolysis)
- Ketone body production (β-hydroxybutyrate as signaling molecule)
- NAD⁺/NADH ratio changes (sirtuin activity modulation)
Secretory outputs:
Epigenetic outputs:
- mtDNA methylation changes (via DNMT3A recruitment)
- Nuclear gene expression via retrograde signaling (Ca²⁺ → NFAT, CREB; ROS → NF-κB, AP-1)
- Histone modifications via acetyl-CoA availability (TCA cycle product)
graph TD
A[Psychosocial Stress] --> B[Autonomic Signal]
A --> C[Inflammatory Signal]
A --> D[Metabolic Signal]
B --> E[Mitochondrial Sensing]
C --> E
D --> E
E --> F[MAM Integration Hub]
F --> G["Ca²⁺ Dynamics"]
F --> H[Lipid Synthesis]
F --> I[Autophagy Regulation]
G --> J[Transduction Outputs]
H --> J
I --> J
J --> K[ATP/ROS Production]
J --> L[Mitokine Secretion]
J --> M[mtDNA Release]
J --> N[Epigenetic Changes]
K --> O[Systemic Physiology]
L --> O
M --> O
N --> O
O --> P[Clinical Disease/Health]
The MIPS model provides the mechanistic substrate for psychosomatic medicine and validates mitochondrial support as a foundational cPNI intervention, not an adjunct therapy.
Relevant patient populations:
- Chronic stress disorders (PTSD, chronic anxiety) — sustained catecholamine signaling impairs mitochondrial Ca²⁺ buffering
- Treatment-resistant depression — inflammation-induced mitochondrial dysfunction (IL-6 >10 pg/mL correlates with antidepressant failure)
- Chronic fatigue syndrome — mitochondrial ATP production ↓20-50% despite normal mtDNA copy number (integration failure)
- Metabolic syndrome — psychosocial stress → cortisol → insulin resistance via mitochondrial oxidative stress
- Fibromyalgia — MAM dysfunction impairs Ca²⁺ handling → muscle pain + fatigue
Metamodel connections:
- Metamodel 0 (Evolutionary mismatch): Modern chronic stress overwhelms mitochondrial adaptation capacity designed for acute threats
- Metamodel 1 (Selfish systems): Mitochondria prioritize self-preservation over cellular needs when stressed (fission → fragmentation → reduced ATP, increased ROS signaling)
- Metamodel 3 (Energy distribution): MIPS determines ATP allocation between survival (immune activation) vs repair (tissue healing)
Biomarkers:
- Plasma FGF21 >200 pg/mL indicates mitochondrial stress
- cf-mtDNA >3,500 copies/mL suggests mitochondrial damage
- Lactate:pyruvate ratio >20:1 indicates oxidative phosphorylation impairment
- 8-OHdG (oxidative mtDNA damage) >15 ng/mg creatinine
Intervention implications:
- Mitochondrial substrates: Q10 (100-300 mg/day for ATP synthesis), L-carnitine (500-2,000 mg/day for fatty acid oxidation), NAD+ precursors (nicotinamide riboside 300 mg/day)
- MAM stabilizers: Omega-3 fatty acids (EPA/DHA) incorporate into MAM membranes → improve Ca²⁺ dynamics
- Stress axis regulation: Meditation, HRV biofeedback reduce catecholamine-induced mitochondrial fission
- Mitohormetic stressors: Exercise, cold exposure, intermittent fasting induce adaptive mitochondrial responses (PGC-1α upregulation)
- Anti-inflammatory diet: Reduces IL-6/TNF-α → preserves mitochondrial biogenesis capacity
Why this matters: A patient presenting with "just stress and fatigue" has measurable mitochondrial dysfunction — treating this mechanistically (not symptomatically) addresses root cause pathology.
- Proposed by Martin Picard (Columbia University) and Orian Shirihai (UCLA) in Cell Metabolism, 2022
- Mitochondria occupy 5-20% of cell volume but integrate 100% of cellular information streams
- MAMs connect mitochondria to ER, nucleus, lysosomes, peroxisomes, Golgi — true information hubs
- Single mitochondrion processes signals from 3-5 different MAM contact sites simultaneously
- Psychosocial stress increases cortisol → inhibits insulin signaling → reduces glucose entry via GLUT4 → forces mitochondrial fatty acid oxidation → increases ROS by 30-50%
- Chronic stress (>6 months) reduces mtDNA copy number by 15-25% in peripheral blood leukocytes
- MOTS-c (mitochondrial ORF of 12S rRNA type-c) is encoded in mtDNA, produced during metabolic stress, acts systemically to improve insulin sensitivity
- Humanin (24-amino acid peptide from 16S rRNA) protects neurons from oxidative stress, declines 50% from age 30 to 70
- cf-mtDNA released during stress activates cGAS-STING pathway → type I interferon production → links mitochondria to innate immunity
- Mitochondrial Ca²⁺ overload (from chronic stress) triggers PTP opening → cytochrome c release → apoptosis initiation
- ROS production is bidirectional signal: low ROS (1-2% of O₂) = adaptive signaling; high ROS (>5%) = damage
- Epigenetic changes at MAMs persist 3-6 months after stressor removal — explains delayed recovery from burnout
- mitochondria — MIPS redefines mitochondrial function from passive energy factories to active information processors
- mitochondria-associated membranes — physical integration sites where sensing converges into coordinated cellular responses
- mitokines — secreted signals (FGF21, GDF15) by which mitochondria communicate stress to distant organs
- mitochondrial-derived peptides — MOTS-c, humanin, SHLP family provide systemic metabolic regulation and neuroprotection
- cell-free mitochondrial DNA — released cf-mtDNA acts as danger signal activating innate immune pathways (TLR9, cGAS-STING)
- stress — psychological stress physically alters mitochondrial dynamics, ROS production, and energy allocation
- psychological stress — MIPS provides molecular mechanism for how thoughts/emotions become cellular pathology
- psychosomatic medicine — MIPS eliminates mind-body dualism by showing shared biochemical pathways
- Insulin — insulin signaling is primary metabolic input to mitochondrial sensing (AKT activation)
- AKT pathway — insulin → PI3K → AKT → mTORC1 + FOXO suppression regulates mitochondrial anabolism
- Autonomic nervous system — catecholamine signaling (β-adrenergic) directly modulates mitochondrial fission/fusion dynamics
- inflammatory cytokines — IL-6, TNF-α suppress PGC-1α → reduce mitochondrial biogenesis, link inflammation to energy failure
- epigenetics — mitochondrial outputs (acetyl-CoA, NAD⁺, SAM) determine histone/DNA methylation capacity
- Methylation — mtDNA methylation changes persist post-stress, encoding cellular "memory" of adversity
- ATP — end product of oxidative phosphorylation, but MIPS shows ATP production is information-dependent, not automatic
- Energy Distribution — mitochondria allocate ATP based on integrated threat assessment (immune vs repair vs growth)
- NAD+ precursors — NR, NMN restore NAD⁺/NADH ratio, improve sirtuin function, enhance mitochondrial resilience
- Q10 — electron transport chain cofactor, declines with age/stress, supplementation improves ATP synthesis capacity
- L-carnitine — shuttles fatty acids into mitochondria, essential when stress forces lipid oxidation pathway
- Depression — inflammation-induced mitochondrial dysfunction (IL-6 >10 pg/mL) predicts SSRI resistance
- Chronic fatigue syndrome — prototypical MIPS failure: sensing intact, integration impaired, transduction outputs mismatch demand
- Fibromyalgia — MAM Ca²⁺ dysregulation hypothesis explains pain + fatigue + cognitive dysfunction triad
- inflammation — bidirectional: inflammation impairs mitochondria (NF-κB suppresses PGC-1α); mitochondrial damage releases DAMPs → inflammation
- Allostatic load — cumulative mitochondrial "wear and tear" from repeated MIPS activation without recovery
- HRV — heart rate variability reflects autonomic tone, which directly modulates mitochondrial dynamics via β-adrenergic signaling
- Cortisol — chronic elevation → insulin resistance → forces mitochondrial fatty acid oxidation → oxidative stress cascade
- metainflammation — low-grade inflammation from metabolic stress directly impairs mitochondrial OXPHOS efficiency
- mitoresilience — mitochondrial capacity to adapt to stressors without functional collapse (trainable via hormesis)
- mitohormesis — adaptive response to mild mitochondrial stress (exercise, fasting) improves long-term MIPS capacity